Display options
Cite
Castrejon I, Toledano E, Rosario MP, et al. Erratum to: Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis. Rheumatol Int. 2015;35(7):1139doi: 10.1007/s00296-015-3264-7.
Castrejon, I., Toledano, E., Rosario, M. P., Loza, E., Pérez-Ruiz, F., & Carmona, L. (2015). Erratum to: Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis. Rheumatology international, 35(7), 1139. https://doi.org/10.1007/s00296-015-3264-7
Castrejon, Isabel, et al. "Erratum to: Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis." Rheumatology international vol. 35,7 (2015): 1139. doi: https://doi.org/10.1007/s00296-015-3264-7
Castrejon I, Toledano E, Rosario MP, Loza E, Pérez-Ruiz F, Carmona L. Erratum to: Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis. Rheumatol Int. 2015 Jul;35(7):1139. doi: 10.1007/s00296-015-3264-7. PMID: 25895647.
Copy Download .nbib Format: NLM
Share it on

Rheumatol Int. 2015 Jul;35(7):1139. doi: 10.1007/s00296-015-3264-7.

Erratum to: Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis.

Rheumatology international

Isabel Castrejon, Esther Toledano, María Piedad Rosario, Estíbaliz Loza, Fernando Pérez-Ruiz, Loreto Carmona

Affiliations

  1. Division of Rheumatology, Rush University Medical Center, 1611 West Harrison Street, Suite 510, Chicago, IL, 60612, USA, [email protected].

PMID: 25895647 DOI: 10.1007/s00296-015-3264-7

[No abstract available.]

Publication Types